Found 950 clinical trials
RSV Vaccine 65 and Older
A Phase 3, open-label, randomized, controlled, multi-country study to evaluate the immune response, safety and reactogenicity of RSVPreF3 OA investigational vaccine when co-administered with FLU HD vaccine in adults aged 65 years and above.
- 0 views
- 25 Aug, 2022
- 1 location
RSV Vaccine for Ages 50-59
A Phase 3, observer-blind, randomized, placebo-controlled study to evaluate the non-inferiority of the immune response and safety of the RSVPreF3 OA investigational vaccine in adults 50-59 years of age, including adults at increased risk of respiratory syncytial virus lower respiratory tract disease, compared to older adults ≥60 years of age …
- 0 views
- 25 Aug, 2022
- 1 location
Flu Vaccine 18+
A Phase 3, Randomized, Observer-blinded Study To Evaluate The Relative safety, Tolerability, Efficacy, And Immunogenicity Of A Modified RNA vaccine Against Influenza Compared To A Licensed Inactivated Influenza vaccine In Healthy Adults ≥65 Years Of Age
- 0 views
- 24 Aug, 2022
- 1 location
Botulism Prevention
A Phase 2, multicenter, randomized, double-blinded, placebo-controlled study to evaluate repeat dose (50 mg and 100 mg) of G03-52-01 administered by IM injection(s) in adult subjects. Approximately 375 subjects will be enrolled in this study.
- 13 views
- 12 Dec, 2022
- 1 location
The study of Cytomegalovirus (CMV)
This study will test a new investigational vaccine against Cytomegalovirus CMV. The new CMV investigational vaccine is being developed to prevent CMV infection. We want to help prevent mothers from passing CMV infection to their infants during pregnancy. Men are included in this study to get a better understanding of …
- 0 views
- 25 May, 2023
- 1 location
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
The primary objective of this study is:To evaluate the efficacy of fostamatinib when used in combination with standard of care (SOC) in subjects hospitalized with COVID-19 without respiratory failure and with certain high risk prognostic factors, as measured by the change in clinical status score.
- 2 views
- 10 Dec, 2021
- 35 locations
Study to Assess the Immunogenicity and Safety of GSK's Meningococcal Group B Vaccine When Administered Concomitantly with GSK's Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age
The purpose of this study is to evaluate the immunogenicity, safety and tolerability of rMenB+OMV NZ and MenACWY vaccines when concomitantly administered to healthy subjects 16-18 years of age.
- 0 views
- 27 Jun, 2022
- 1 location
A Phase 3, Placebo-controlled, Randomized, Observer-blinded Study To Evaluate The Efficacy, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older
A Phase 3, Placebo-controlled, Randomized, Observer-blinded Study To Evaluate The Efficacy, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older
- 1672 views
- 25 Mar, 2021
- 1 location
Phase I Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)
This research study will test one of 2 different Zika viruses (ZIKV) so we can find a ZIKV we can safely give to people in the future to test vaccines. If you join, you will have one or more screening visits. If you are healthy and your labs are normal, you …
- 3 views
- 09 Dec, 2021
- 1 location
Family trip to Asia? Mosquitoes spread the disease Japanese Encephalitis all over Asia. Your child(or the child of someone you know) may be eligible to participate in a research study being conducted by Passport Health and Tampa Clinical Research.
Family trip to Asia? Mosquitoes spread the disease Japanese Encephalitis all over Asia. Your child(or the child of someone you know) may be eligible to participate in a research study being conducted by Passport Health and Tampa Clinical Research.
- 38 views
- 08 Nov, 2020
- 1 location